Skip to main content
FTRE
NASDAQ Life Sciences

Fortrea Reports Q1 Revenue of $636.5M, Adjusted EPS $0.16; Reaffirms Full-Year Guidance

feedReported by Wiseek News
Sentiment info
Neutral
Importance info
8
Price
$12.26
Mkt Cap
$1.145B
52W Low
$3.97
52W High
$18.67
Market data snapshot near publication time

summarizeSummary

Fortrea Holdings Inc. announced its first-quarter 2026 results, reporting revenue of $636.5 million, adjusted EBITDA of $47.0 million, and adjusted diluted EPS of $0.16. The company also posted a GAAP net loss of $(23.6) million and negative free cash flow of $(25.0) million for the quarter. Importantly, Fortrea reaffirmed its full-year 2026 guidance for revenue and adjusted EBITDA, and reported a strong book-to-bill ratio of 1.15x. This earnings report provides critical financial updates following the significant net loss reported in the prior year's 10-K. Traders will be evaluating the mixed results, balancing the positive adjusted EPS and confirmed guidance against the GAAP loss and negative cash flow. Future performance will hinge on the company's ability to improve GAAP profitability and cash generation while executing on its backlog.

At the time of this announcement, FTRE was trading at $12.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $3.97 to $18.67. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed FTRE - Latest Insights

FTRE
May 05, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
FTRE
May 05, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
8
FTRE
May 05, 2026, 6:12 AM EDT
Filing Type: 8-K
Importance Score:
8
FTRE
Apr 27, 2026, 6:11 AM EDT
Filing Type: DEF 14A
Importance Score:
7
FTRE
Feb 26, 2026, 4:04 PM EST
Filing Type: 10-K
Importance Score:
9
FTRE
Feb 26, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
8